Envoy Medical, Inc. (COCHW) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
4875 WHITE BEAR PARKWAY WHITE BEAR LAKE, MN 55110 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 5,483 | 4,218 | 108 | 150 | |||
| Cash and cash equivalent | 5,483 | 4,218 | 108 | 150 | |||
| Receivables | 818 | 246 | |||||
| Inventory, net of allowances, customer advances and progress billings | 1,708 | 1,404 | |||||
| Inventory | 1,708 | 1,404 | |||||
| Prepaid expense | 113 | 713 | |||||
| Other undisclosed current assets | 1,375 | 957 | |||||
| Total current assets: | 9,384 | 6,825 | 220 | 863 | |||
| Noncurrent Assets | |||||||
| Property, plant and equipment | 1,275 | 351 | |||||
| Asset, held-in-trust | 430,047 | 425,038 | |||||
| Other undisclosed noncurrent assets | 879 | 464 | 354 | 1,003 | |||
| Total noncurrent assets: | 2,154 | 815 | 430,401 | 426,040 | |||
| TOTAL ASSETS: | 11,538 | 7,640 | 430,621 | 426,904 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 6,068 | 6,167 | 5,123 | 2,678 | |||
| Accounts payable | 1,652 | 1,554 | 1,178 | 619 | |||
| Accrued liabilities | 4,416 | 4,613 | 3,946 | 2,059 | |||
| Derivative instruments and hedges, liabilities | 311 | ||||||
| Other liabilities | 573 | ||||||
| Other undisclosed current liabilities | 897 | 158 | 2,187 | ||||
| Total current liabilities: | 7,538 | 6,636 | 7,310 | 2,678 | |||
| Noncurrent Liabilities | |||||||
| Liabilities, other than long-term debt | 2,662 | 332 | |||||
| Accounts payable and accrued liabilities | 1,771 | ||||||
| Other liabilities | 891 | ||||||
| Derivative instruments and hedges, liabilities | 332 | ||||||
| Other undisclosed noncurrent liabilities | 20,180 | 2,434 | 11,479 | 35,939 | |||
| Total noncurrent liabilities: | 22,842 | 2,766 | 11,479 | 35,939 | |||
| Total liabilities: | 30,380 | 9,402 | 18,789 | 38,617 | |||
| Temporary equity, including noncontrolling interest | 429,747 | 425,000 | |||||
| Equity | |||||||
| Equity, attributable to parent, including: | (18,842) | (1,762) | (17,915) | (36,714) | |||
| Common stock | |||||||
| Additional paid in capital | 266,013 | 255,596 | |||||
| Accumulated other comprehensive loss | (123) | (118) | |||||
| Accumulated deficit | (284,734) | (257,242) | (17,916) | (36,715) | |||
| Other undisclosed equity, attributable to parent | 2 | 2 | 1 | 1 | |||
| Total equity: | (18,842) | (1,762) | (17,915) | (36,714) | |||
| TOTAL LIABILITIES AND EQUITY: | 11,538 | 7,640 | 430,621 | 426,904 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|---|
| Revenues | 225 | 316 | ||||
| Cost of revenue | (742) | (2,405) | ||||
| Cost of product and service sold | (742) | (789) | ||||
| Gross profit: | (517) | (2,089) | ||||
| Operating expenses | (18,739) | (16,282) | (4,888) | (5,205) | ||
| Operating loss: | (19,256) | (18,371) | (4,888) | (5,205) | ||
| Nonoperating income (expense) | (1,539) | (11,537) | 6,125 | 38 | ||
| Investment income, nonoperating | 6,125 | 38 | ||||
| Interest and debt expense | (816) | |||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (21,611) | (29,908) | 1,237 | (5,167) | ||
| Other undisclosed income from continuing operations before income taxes | 19,499 | |||||
| Income (loss) from continuing operations before income taxes: | (21,611) | (29,908) | 20,735 | (5,167) | ||
| Income tax expense (benefit) | (1,502) | 1,085 | ||||
| Income (loss) from continuing operations: | (21,611) | (29,908) | 19,234 | (4,082) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (4,082) | |
| Other undisclosed net income | 3,831 | |||||
| Net income (loss): | (21,611) | (29,908) | 19,234 | (252) | ||
| Other undisclosed net income attributable to parent | 816 | |||||
| Net income (loss) attributable to parent: | (20,795) | (29,908) | 19,234 | (252) | ||
| Other undisclosed net loss available to common stockholders, basic | (7,178) | |||||
| Net income (loss) available to common stockholders, diluted: | (27,973) | (29,908) | 19,234 | (252) | ||
Comprehensive Income ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | (21,611) | (29,908) | 19,234 | (252) | ||
| Other comprehensive income (loss) | (5) | |||||
| Comprehensive income (loss): | (21,616) | (29,908) | 19,234 | (252) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 816 | (3) | ||||
| Comprehensive income (loss), net of tax, attributable to parent: | (20,800) | (29,911) | 19,234 | (252) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.